Latest Announcements

Indian Card Clothing Company Limited has informed the Exchange about General Updates, specifically regarding the 72nd Annual General Meeting ('AGM') of the Members of the Company and Annual Report for the Financial Year 2025-26.

WeWork India Management Limited has informed the Exchange that the Board of Directors has accorded in-principle approval for setting up a 10 MWp captive solar power plant in Karnataka, aimed at reducing electricity costs, increasing renewable energy use, and supporting sustainability objectives.

Digjam Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026.

Karur Vysya Bank Limited has informed the Exchange about ESG rating assigned by M/s. NSE Sustainability Ratings & Analytics for the Financial Year 2025-26.

Puravankara Limited has informed the Exchange about Intimation of Letter sent to shareholders who have not registered their email address providing the web-link of the Annual Report.

Starteck Finance Limited has informed the Exchange about the re-appointment of Mr. Nilesh Parikh as an Independent Director of the Company for a second term of 5 consecutive years subject to approval of Shareholders.

Happiest Minds Technologies Limited has informed the Exchange about the publication of a postal ballot notice in newspapers, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Aarti Surfactants Limited has informed the Exchange about the transition of its credit rating agency from CARE Ratings Limited to CRISIL Ratings Limited, with CRISIL Ratings upgrading the company's long-term bank loan facilities to Crisil A-/Stable from CARE BBB+.

Knowledge Marine & Engineering Works Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The company's board meeting is scheduled to be held on September 08, 2026, to consider and approve raising of funds through a private placement or preferential allotment. The trading window for dealing in the company's securities is closed from September 03, 2026, for all directors, promoters, and connected persons.

Gaudium IVF and Women Health Limited has informed the Exchange regarding the dispatch of physical letters to members whose email addresses are not registered with the Company/Registrar & Share Transfer Agent/Depository Participants, containing the web-link and exact navigation path to access the Annual Report for the Financial Year 2025-26.

Heranba Industries Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026.

Paramount Communications Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026.

Puravankara Limited has informed the Exchange regarding 40th Notice of Annual General Meeting to be held on September 25, 2026.

Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026

Cipla Limited has announced an exclusive partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to Keytruda (Pembrolizumab) in the US.

Shukra Pharmaceuticals Limited has rescheduled its 33rd Annual General Meeting (AGM) to September 28, 2026, due to unavoidable administrative exigencies. The revised book closure dates are September 22-28, 2026.

International Conveyors Limited has informed the Exchange about the submission of a newspaper publication regarding the Notice of 53rd Annual General Meeting of the Company to be held on September 24, 2026.

Orchid Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026, where the Board of Directors approved the appointment of Cost Auditors for FY 2026-27, appointment of Mr. Arjun Dhanuka as Whole-Time Director, and other matters.

Gujarat Mineral Development Corporation Limited has informed the Exchange about the details of its upcoming 63rd Annual General Meeting (AGM), including the record date, dividend payment date, and venue.

Cohance Lifesciences Limited has announced two proposed transactions to strengthen its Antibody-drug Conjugate (ADC) strategy: an additional investment of USD 13 million in NJ Bio and a controlling investment of USD 5 million in Aruka Bio.